艾塞那肽缓释微球的制备和体外释放的研究
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Preparation of sustained-release microspheres containing exenatide and their in vitro release
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的制备载艾塞那肽的聚乳酸-羟基乙酸共聚物[poly (lactic-co-glycolicacid),PLGA]微球,并对其体外释药特性进行考察。方法以聚乳酸-羟基乙酸共聚物为载体,采用凝聚法(W/O/O)制备载艾塞那肽缓释注射微球,建立了高效液相色谱测定艾塞那肽含量的方法和微球中药物提取方法,考察微球粒径大小、外观、包封率、载药量等理化性质,并对微球体外释放特性进行了考察。结果微球球形较圆整,平均粒径为(51.2±1.97)μm,实际载药量为(4.50±0.13)%,包封率在(96.5±2.68)%,

    Abstract:

    [Abstract] Objective: To preparation exenatide loaded poly (lactic-co-glycolicacid) (PLGA) microspheres and to evaluate its release behavior in vitro. Methods: Exenatide PLGA microspheres were prepared by W/O/O method. The content and in vitro cumulative release was determined by a HPLC method, the physical and chemical characteristics of microspheres, including the mean diameter, morphology, drug entrapment efficiency and loading efficiency were evaluated. Results: The prepared microspheres were well-shaped, with mean diameter of (51.2±1.97)μm. The drug loading and encapsulation efficiency were (4.50±0.13)% and (88.6±0.73)%, respectively. The first day burst release was (13.19±1.39)%. The cumulative in vitro release was up to (88.6±0.73)% in 28 day. Conclusion: The exenatide can encapsulated in microspheres to yield a one-month continuous release using biodegradable polymers PLGA as the carrier material and the process is stable and reproducible.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2011-03-21
  • 最后修改日期:2011-07-01
  • 录用日期:2011-07-05
  • 在线发布日期: 2011-07-22
  • 出版日期:
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭